DelveInsight has launched a new report on Rosacea Market Insights, Epidemiology and Market Forecast-2030
DelveInsight’s “Rosacea – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Rosacea, historical and forecasted epidemiology as well as the Rosacea market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Rosacea market report provides current treatment practices, emerging drugs, Rosacea market share of the individual therapies, current and forecasted Rosacea market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Rosacea treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Request for :- Rosacea free sample page
Rosacea Epidemiology
The Rosacea epidemiology division provide insights about historical and current Rosacea patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Rosacea Drug Chapter
Drug chapter segment of the Rosacea report encloses the detailed analysis of Rosacea marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Rosacea clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases
Report key facts:-
1. Among the European countries, Germany had the highest prevalent population of Rosacea with 8,383,943 cases in 2017, followed by France which had prevalent population of 6,082,002 in 2017. On the other hand, Italy had the lowest prevalent population of 3,217,083 in 2017.
2. The estimates suggest that higher prevalence of Rosacea was found in the United States with 16,652,170 cases in 2017.
3. As per DelveInsight analysis, highest cases are found to be of Rosacea Erythematotelangiectatic rosacea (ETR), followed by Papulopustular rosacea, Phymatous rosacea, and Ocular rosacea in United States. According to DelveInsight, Rosacea subtype 1, subtype 2, subtype 3 and subtype 4 is expected to increase, by 2030.
“According to DelveInsight analysis, the prevalence of Rosacea is high in females than in males”
Table of Contents
1. Key Insights
2. Executive Summary of Rosacea
3. Competitive Intelligence Analysis for Rosacea
4. Rosacea: Market Overview at a Glance
4.1. Rosacea Total Market Share (%) Distribution in 2017
4.2. Rosacea Total Market Share (%) Distribution in 2030
5. Rosacea: Disease Background and Overview
6. Patient Journey
7. Rosacea Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Rosacea Treatment and Management
8.2. Rosacea Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Rosacea Treatment
11. Marketed Products
12. Emerging Therapies
13. Rosacea: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Rosacea
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Why should you buy this report?
Related Reports:-
1. Rosacea – Pipeline Insights, 2020
2. Rosacea – Epidemiology Forecast to 2030
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/